Single-Dose HPV Vaccine Evaluation Consortium - FAQ document

Human papilloma virus (HPV) causes almost all cases of cervical cancer. Most of these deaths occur in
low- and middle-income countries, but worldwide vaccine coverage in girls under 15 years of age was
only 21 percent in 2022.

In response to a strong and growing evidence base, in December 2022, the World Health Organization
(WHO) endorsed an alternative single-dose HPV vaccination schedule in women and girls ages 920.

This document provides some frequently asked questions and answers about the evidence around single-dose HPV vaccination and the current policy landscape.